| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.16B | 31.18B | 37.31B | 30.40B | 22.92B | 21.30B |
| Gross Profit | 8.99B | 11.09B | 14.72B | 10.23B | 6.41B | 5.62B |
| EBITDA | 7.47B | 9.47B | 11.59B | 8.69B | 4.93B | 4.96B |
| Net Income | 4.14B | 5.75B | 7.30B | 5.40B | 3.04B | 2.50B |
Balance Sheet | ||||||
| Total Assets | 82.64B | 81.39B | 87.80B | 72.55B | 62.61B | 58.72B |
| Cash, Cash Equivalents and Short-Term Investments | 20.76B | 17.42B | 22.34B | 19.37B | 22.44B | 16.63B |
| Total Debt | 39.00M | 9.00M | 1.00M | 7.00M | 17.00M | 30.00M |
| Total Liabilities | 8.25B | 7.59B | 14.90B | 10.14B | 6.55B | 5.25B |
| Stockholders Equity | 74.37B | 73.79B | 72.88B | 62.40B | 56.05B | 53.47B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.00B | 4.54B | 34.00M | 6.80B | 1.45B |
| Operating Cash Flow | 0.00 | 4.55B | 7.79B | 2.34B | 7.62B | 3.37B |
| Investing Cash Flow | 0.00 | -5.40B | -16.03B | -4.35B | -954.00M | -1.94B |
| Financing Cash Flow | 0.00 | -2.99B | -1.39B | -1.03B | -826.00M | -1.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥29.74B | 11.37 | ― | 3.21% | 9.61% | 173.72% | |
75 Outperform | ¥55.77B | 11.56 | 10.88% | 4.46% | -1.14% | 34.15% | |
74 Outperform | ¥38.97B | 26.79 | ― | 3.24% | 1.83% | -8.54% | |
72 Outperform | ¥31.64B | 15.35 | ― | 3.84% | -3.41% | -12.83% | |
69 Neutral | ¥61.84B | 17.37 | ― | 4.32% | -31.99% | -44.75% | |
63 Neutral | ¥237.63B | 11.84 | -14.04% | 3.06% | -7.36% | -574.56% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |